Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAOK1 | Q7L7X3 | 5/20 | 0.62 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | TAOK3 | Q9H2K8 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5652656 | 0.88 | TAOK1 (0.61) | TAOK1SCN3AKDM4EALDH1A1TAOK3 | |
| SCHEMBL5652174 | 0.88 | TAOK3 (0.61) | TAOK1SCN3AKDM4EALDH1A1TAOK3 | |
| SCHEMBL5652352 | 0.86 | TAOK1 (0.62) | TAOK1SCN3AKDM4EALDH1A1TAOK3 | |
| SCHEMBL5653054 | 0.83 | TAOK1 (0.64) | TAOK1SCN3AKDM4EALDH1A1TAOK3 | |
| SCHEMBL5654657 | 0.83 | TAOK1 (0.67) | TAOK1KDM4EFFAR1ALDH1A1TAOK3 | |
| SCHEMBL31458158 | 0.77 | TAOK1 (1.00) | TAOK1KDM4EALDH1A1TAOK3LMNA | |
| SCHEMBL5286330 | 0.77 | TAOK1 (1.00) | TAOK1KDM4EALDH1A1TAOK3LMNA | |
| SCHEMBL31458350 | 0.72 | TAOK1 (1.00) | TAOK1TAOK3 | |
| SCHEMBL5653384 | 0.72 | TAOK1 (1.00) | TAOK1TAOK3 | |
| SCHEMBL5652164 | 0.71 | TAOK3 (0.66) | TAOK1ALDH1A1TAOK3HTTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070208166-A1 | Tao Kinase Modulators And Method Of Use | EXELIXIS, INC. (US) | 2007-09-06 | — | — | US | claimed |
| US-20070208166-A1 | Tao Kinase Modulators And Method Of Use | EXELIXIS, INC. (US) | 2007-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208166-A1 | Tao Kinase Modulators And Method Of Use | TAOK1, TAOK3, MAP3K6 | TAOK1 1/4885SCN3A 4033/4885KDM4E 1538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.